Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pittaluga

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Bacteriology|April 1, 1993
Identification of a genetic element (psr) which negatively controls expression of Enterococcus hirae penicillin-binding protein 5M Ligozzi, F Pittaluga, R Fontana
Antimicrobial Agents and Chemotherapy|February 1, 1996
Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faeciumM Ligozzi, F Pittaluga, R Fontana
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1996
Intrinsic penicillin resistance in enterococciR Fontana, M Ligozzi, F Pittaluga, et al.
International Journal of Systematic Bacteriology|January 1, 1992
Analysis of bacteriolytic activity patterns, a novel approach to the taxonomy of enterococciR Pompei, M C Thaller, F Pittaluga, et al.
Transplantation Proceedings|September 23, 2014
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplantF Tandoi, E Nada, F Pittaluga, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trialR Sostegni, V Ghisetti, F Pittaluga, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Bacteriology|April 1, 1993
Identification of a genetic element (psr) which negatively controls expression of Enterococcus hirae penicillin-binding protein 5M Ligozzi, F Pittaluga, R Fontana
Antimicrobial Agents and Chemotherapy|February 1, 1996
Modification of penicillin-binding protein 5 associated with high-level ampicillin resistance in Enterococcus faeciumM Ligozzi, F Pittaluga, R Fontana
Microbial Drug Resistance (Larchmont, N.Y.)|July 1, 1996
Intrinsic penicillin resistance in enterococciR Fontana, M Ligozzi, F Pittaluga, et al.
International Journal of Systematic Bacteriology|January 1, 1992
Analysis of bacteriolytic activity patterns, a novel approach to the taxonomy of enterococciR Pompei, M C Thaller, F Pittaluga, et al.
Transplantation Proceedings|September 23, 2014
Minimization of anti-hepatitis B surface antigen immunoglobulins for prophylaxis of hepatitis B viral recurrence in the first month after liver transplantation: the meaning of HBsAg quantitative level at the time of transplantF Tandoi, E Nada, F Pittaluga, et al.
Hepatology (Baltimore, Md.)|August 8, 1998
Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trialR Sostegni, V Ghisetti, F Pittaluga, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2016
HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of responseG A Niro, A Smedile, R Fontana, et al.
Pageof 1